Invention Grant
- Patent Title: Dopamine D3 receptor antagonists
-
Application No.: US15975466Application Date: 2018-05-09
-
Publication No.: US10239870B2Publication Date: 2019-03-26
- Inventor: Susanna Cremonesi , Fabrizio Micheli , Teresa Semerano , Luca Tarsi
- Applicant: Indivior UK Limited
- Applicant Address: GB Slough
- Assignee: Indivior UK Limited
- Current Assignee: Indivior UK Limited
- Current Assignee Address: GB Slough
- Agency: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
- Agent Edward D. Grieff
- Priority: GB1419430.2 20141031; GB1419433.6 20141031
- Main IPC: C07D413/14
- IPC: C07D413/14 ; C07D493/08 ; C07D471/04 ; C07D417/14 ; C07D401/14 ; C07D403/12 ; C07D405/14 ; C07D403/14 ; C07D409/14
Abstract:
The disclosure is directed to novel dopamine D3 receptor antagonists, processes for their preparation, intermediates used in these processes, pharmaceutical compositions containing them and their use in therapy, including treating drug dependency and psychosis.
Public/Granted literature
- US20180282318A1 DOPAMINE D3 RECEPTOR ANTAGONISTS Public/Granted day:2018-10-04
Information query
